TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) - ANVISA Registration 10345162404

Access comprehensive regulatory information for TOTAL NUCLEAR ANTIBODY FOR HEPATITIS B VIRUS (ANTI-HBCAG) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10345162404 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Jul 05, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10345162404
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162404
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10345162404

25351040724202099

01449930000190

Company Information

United Kingdom
PT: REINO UNIDO

Dates and Status

Jul 05, 2021

05/07/2031

09/18/2025 19:00:01

Registration Details

10345162404

25351040724202099

01449930000190

Company Information

Dates and Status

Jul 05, 2021

05/07/2031

09/18/2025 19:00:01